We are pleased to announce a strategic agreement with Blue Elaf Medical
Fin-Ceramica Faenza S.p.A. and Blue Elaf Medical W.L.L have signed a commercial agreement for the marketing of product for cartilage regeneration in Bahrain, Saudi Arabia, Jordan and Kuwait.
Finceramica, a leading Italian company in the field of bioceramics and biomaterials for orthopedics and Blue Elaf Medical, a company specialized in the distribution of medical devices and equipment, have announced a commercial agreement for the Middle East region.
The agreement covers the marketing of Finceramica's medical devices such as MaioRegen, a complete system for cartilage and ostehochondral regeneration, and will enable the company to enter new markets and increase its visibility and competitiveness in the Middle East, where there is a growing demand for high-quality solutions for joint diseases.
The agreement will also benefit Blue Elaf Medical, which will be able to offer its clients a portfolio of innovative and certified products made in Italy.
"We are very happy to partner with Blue Elaf Medical, a reliable and professional company in the Middle East region. We believe that our medical devices will provide a great value for surgeons and patients who are looking for optimal and tailored solutions for their orthopedical needs. We look forward to a fruitful and long-lasting collaboration" said Michele Pretto, International Product Manager of Finceramica.
"We are thrilled to join forces with Finceramica Faenza, a world-renowned company in the field of bioceramics and biomaterials. We are impressed by their medical devices, which combine quality and innovation. We are confident that this agreement will create a win-win situation for both parties and will improve the health and well-being of many patients in the region", said Mr. Fadi Fawzi, CEO of Blue Elaf Medical.